MDFA and the eye health community is saddened to learn of the passing of Mr. Richard Grills
The 2022 Supporter Survey results are in.
Specsavers and Macular Disease Foundation Australia have begun a strategic scoping partnership.
Researchers confirm the AREDS2 formulation is safe for use over a decade.
Faricimab has taken one step closer towards clinics in Australia.
MDFA strives to address challenges for people receiving intravitreal injections.
MDFA teams up with Healthily to deliver education via GPs.
MDFA offers Peer to Peer phone calls as well as peer support groups, both face-to-face and online.
Sadly, eye injections came too late for Cheryl Chamberlain. But thousands of Australian patients will now be able to stick to this sight-saving treatment after both major political parties rejected a proposed Medicare rebate cut.